Yucai Wang

Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium

Yucai Wang, Preetesh Jain, Frederick L. Locke et al. · Journal of Clinical Oncology · 2023 · 155 citations · Full text

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

Yucai Wang, Marcella Tschautscher, Kari G. Rabe et al. · Haematologica · 2019 · 128 citations · Full text

Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network

Damien C. Weber, Yucai Wang, Robert C. Miller et al. · Neuro-Oncology · 2014 · 122 citations · Full text

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

Kai Rejeski, Doris K. Hansen, Radhika Bansal et al. · Journal of Hematology & Oncology · 2023 · 95 citations · Full text

Hematological Malignancy, Car-hematotox Score, Medicine +9

Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma

Michael Wang, Wojciech Jurczak, Pier Luigi Zinzani et al. · Journal of Clinical Oncology · 2023 · 89 citations · Full text